More than 100 years
serving the industry
Life solutions
Energy solutions
Focus on
Our News
Boccard at CEBioFORUM 2026 | Warsaw
Boccard at the Pitch Sessions during CEBioForum 2026 Meet the innovators shaping the future of life sciences. At
More news
OUR SOLUTIONS
For your markets and industries
Food
& Ingredients
Food
& ingredients
Discover
Brewery &
Distillery
Brewery &
Distillery
Discover
Cosmetics
& Hygiene
Cosmetics
& Hygiene
Discover
Pharma & Biotech
Pharma & Biotech
Discover
Energy
Nuclear
Energy
Nuclear
Discover
Advanced
Energies
Advanced
Energies
Discover
Oil
& Gas
Oil
& Gaz
Discover
Steel
& Mining
Steel
& Mining
Discover
Your projects
Our Achievements
Dismantling of Superphénix NNS in Creys-Malville, France
The Boccard teams were involved in the design phase as well as in the studies and turnkey construction of two treatment lines designed to transform
Fermentation in Biotech: E. coli for Recombinant Protein at R&D and Pilot Scale
Discover how E. coli recombinant protein fermentation scale up moves from 5 L glass to a 30 L seed and 150 L main bioreactor, with inline pH/DO/glucose analytics, CIP/SIP and compact centrifuge, sonication and ultrafiltration. A temperature and pH controlled waste inactivation tank enables safe discharge in a limited space. With TEKINBIO™ and Track Advance, teams gain tighter control and traceable scale‑up for reliable industrialisation.
Scaling up GLP-1 Production to Meet Global Demand: Boccard’s Contribution to a High-Growth Therapeutic Segment
As demand for GLP‑1 therapies grows in obesity and Type 2 diabetes care, manufacturers must rapidly scale production while meeting strict GMP requirements. This case study shows how Boccard delivered a robust and scalable GLP‑1 production line.
Focus on
Our Expertise and Services
About
Boccard at a glance
You want
more information ?
Our Customers
They trust us
